Information for medical professionals from market surveillance of medicinal products

Pharmacovigilance in the spotlight

Learning from adverse reaction reports – cases from pharmacovigilance
The purpose of this new section is to use real-life case reports from Switzerland as a reminder of possible side effects that professionals should be aware of in day-to-day clinical practice. The only way to protect patients against undesirable effects is to take account of and report medicinal product risks.

Latest contributions


26.11.2022

Fluoroquinolones and tendon inflammation/ruptures

Fluoroquinolones | moxifloxacin | iprofloxacin | levofloxacin | tendon rupture | Achilles tendon

21.11.2022

Amiodarone and hyperthyroidism

Hyperthyroidism | amiodarone | thyroiditis | iodine level

Swissmedic Vigilance-News

Topical aspects of medicinal product risk assessment
Twice a year, the Safety of Medicines Division reports on current topics relating to adverse reaction surveillance and the evaluation of safety signals. Swissmedic's "Vigilance News" appears twice a year as an online resource.

Current Editions


22.11.2022

Vigilance-News Edition 29

In this edition:

  • Reports of urticaria after booster vaccination with Spikevax
  • Contrast-induced neurotoxicity
  • Swiss Haemovigilance System: Regulatory aspects and transfusion reactions
  • Statistical Review 2021: Pharmacovigilance for human medicinal products, vaccinovigilance, vigilance for veterinary medicinal products

Previous issues


23.05.2022

Vigilance-News Edition 28

In this edition:

COVID-19 immunisation:

  • Modification of the Information for healthcare professionals since authorisation
  • Myocarditis, thromboembolic events, multiple sclerosis
  • Persistent headache
  • Methods of signal detection / ”Observed versus expected” analyses

29.11.2021

Vigilance-News Edition 27

In this edition:

COVID-19 immunisation:

  • Myocarditis/pericarditis: Case reports received by Swissmedic
  • Menstrual disorders – facts, possible causes, unanswered questions
  • Recent study findings and recommendations
    for vaccination of pregnant women
  • International cooperation
    in the area of pharmacovigilance

29.06.2021

Vigilance-News Edition 26

In this edition:

  • COVID-19 vaccines: reporting suspected side effects correctly
  • Case report “COVID arm”
  • AEFI after immunisation with COVID-19 vaccines: Herpes zoster, neuralgic amyotrophy, immune thrombocytopenia

All issues